HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.

AuthorsO G Ottmann, R A Larson, H M Kantarjian, P D le Coutre, M Baccarani, A Hochhaus, D W Kim, X Fan, S Novick, F J Giles
JournalLeukemia (Leukemia) Vol. 27 Issue 6 Pg. 1411-3 (Jun 2013) ISSN: 1476-5551 [Electronic] England
PMID23138184 (Publication Type: Clinical Trial, Phase II, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Pyrimidines
  • Protein-Tyrosine Kinases
  • nilotinib
Topics
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Philadelphia Chromosome
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy, genetics)
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Pyrimidines (therapeutic use)
  • Recurrence
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: